Biogen to gain from Novo Nordisk Alzheimer’s failure, says Jefferies
Go back to Biogen to gain from Novo Nordisk Alzheimer’s failure, says Jefferies| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 224.03 +7.99 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.04 | 52 Week High | $333.65 | |||
| Open | $218.20 | 52 Week Low | $223.02 | |||
| Day High | $224.47 | P/E | 28.69 | |||
| Day Low | $216.97 | EPS | $7.81 | |||
| Volume | 565,573 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.85 +1.73 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.12 | 52 Week High | $59.00 | |||
| Open | $46.05 | 52 Week Low | $32.80 | |||
| Day High | $46.94 | P/E | N/A | |||
| Day Low | $45.91 | EPS | $0.00 | |||
| Volume | 6,857,406 | |||||
